---
title: "OBG SCIENTIFIC DIVISION LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/372b3e11-0252-50cd-bfab-1e1fa7fe6aaa
json: https://whiteintel.dev/api/public/dossier/372b3e11-0252-50cd-bfab-1e1fa7fe6aaa
identifier: oo:GB-COH-09987650
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# OBG SCIENTIFIC DIVISION LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-09987650`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/372b3e11-0252-50cd-bfab-1e1fa7fe6aaa  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/372b3e11-0252-50cd-bfab-1e1fa7fe6aaa  

## Ownership & control

### Owners / controllers

- **Mr Gerald Francis O'Brien** (beneficial owner) — https://whiteintel.dev/entity/a680f4de-d81c-528c-91cd-3e8b3934c1a8
- **Mrs Bridget Christina O'Brien** (beneficial owner) — https://whiteintel.dev/entity/2df9567c-76b7-5c31-b633-6e996adfa3f7
- **OBG SCIENTIFIC DIVISION LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/372b3e11-0252-50cd-bfab-1e1fa7fe6aaa
- **Mr Gerald Francis O'Brien** (beneficial owner) — https://whiteintel.dev/entity/c3c3ac79-5e20-4942-add0-c2916ee45870
- **Mrs Bridget Christina O'Brien** (beneficial owner) — https://whiteintel.dev/entity/e03071bb-d2cd-404a-a7c1-8b47af04b19b
- **Obg Pharmaceuticals Ltd** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/86dae217-ef28-4dd7-9c93-d60cd75d74c8

### Holdings / subsidiaries

- **OBG CONSUMER SCIENTIFIC LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/df1d265b-a711-5fe9-93e8-e0bc0c777dca
- **OBG CONSUMER REG SCIENTIFIC LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/a0a58753-7631-5c11-8bfc-1abfa2b6fda2
- **AYRTON SAUNDERS INHALATION LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/cc4ba950-d029-5df5-8644-108688ff86d5
- **OBG CONSUMER REG SCIENTIFIC LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/a0a58753-7631-5c11-8bfc-1abfa2b6fda2
- **OBG CONSUMER SCIENTIFIC LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/df1d265b-a711-5fe9-93e8-e0bc0c777dca
- **AYRTON SAUNDERS INHALATION LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/cc4ba950-d029-5df5-8644-108688ff86d5

### UBO chain (walk to the ultimate owner)

A **6-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `09987650`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2016-02-04
- **Registered office:** Ayrton House, Commerce Way, Liverpool, L8 7BA, England
- **SIC:** 82990

### Officers

- DIDLICK, Philip James — director · British · appointed 2016-02-04
- O'BRIEN, Gerald Francis — director · British · appointed 2016-02-04
- O'BRIEN, Padraic Marc — director · British · appointed 2016-02-04
- BROMILEY, Mark — secretary · appointed 2021-07-02 · resigned 2025-03-07
- DIDLICK, Philip — secretary · appointed 2016-02-04 · resigned 2021-07-02
- BROMILEY, Mark — director · British · appointed 2021-11-02 · resigned 2025-03-07

### Beneficial owners (Persons with Significant Control)

- Obg Pharmaceuticals Ltd — 75–100% shares · corporate PSC · England — since 2024-01-12
- Mr Gerald Francis O'Brien — significant influence or control · individual PSC · England — ceased 2024-01-12
- Mrs Bridget Christina O'Brien — significant influence or control · individual PSC · England — ceased 2024-01-12

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/09987650
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/09987650

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **OBG SCIENTIFIC DIVISION LIMITED** — https://whiteintel.dev/entity/372b3e11-0252-50cd-bfab-1e1fa7fe6aaa · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **OBG SCIENTIFIC DIVISION LIMITED**. Human view: https://whiteintel.dev/entity/372b3e11-0252-50cd-bfab-1e1fa7fe6aaa · Structured JSON: https://whiteintel.dev/api/public/dossier/372b3e11-0252-50cd-bfab-1e1fa7fe6aaa._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._